IP Library Granted Patent US 11,213,622
Granted Patent B2
US 11,213,622 · App. 16/560,497 · Granted Jan 4, 2022

Usability features for integrated insulin delivery system

Inventors: Mark Sloan (Redwood City, CA); Marc B. Taub (Mountainview, CA); Gary A. Hayter (Oakland, CA); Wesley Scott Harper (Alameda, CA); Erwin S. Budiman (Fremont, CA); Charles Wei (Fremont, CA)
Assignee: ABBOTT DIABETES CARE INC.
A61M5/1723A61B5/14532A61B5/4839A61B5/746A61M5/142G08B21/0453G08B21/182G16H20/17G16H50/50A61M2005/14296A61M2205/18A61M2205/3569A61M2205/52A61M2230/201G16H40/67
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,213,622
App. No.
16/560,497
Granted
Jan 4, 2022
Kind
B2
Abstract

Methods and systems for delaying alarms that include detecting an analyte level using an analyte sensor; and delaying the annunciation of an analyte alarm after the analyte level crosses an analyte threshold, wherein the delay is based on one or both of (1) a magnitude of difference between the analyte level and the analyte threshold and (2) a duration of time in which the analyte level has crossed the analyte threshold.

Claims (25)

1. A method comprising:

detecting an analyte level of a user using an analyte sensor; and

delaying an annunciation of an analyte alarm after the analyte level crosses an analyte threshold, wherein an amount of the delay is based on a duration of time in which the analyte level has not exceeded the analyte threshold.

2. The method of claim 1 , wherein the analyte threshold is a low analyte threshold.

3. The method of claim 1 , wherein the analyte level is a glucose level.

4. The method of claim 3 , wherein the analyte level is an interstitial glucose level.

5. The method of claim 1 , further comprising sounding an alarm after the delay.

6. The method of claim 5 , wherein sounding the alarm after the delay is performed by an electronic device in communication with the analyte sensor.

7. The method of claim 6 , wherein the electronic device comprises a display for user input and output communication.

8. The method of claim 1 , wherein the electronic device is further configured to recommend medication based on the analyte level.

9. The method of claim 1 , wherein the duration of time corresponds to a duration the analyte level was in a euglycemic range prior to exceeding the analyte threshold.

10. An analyte monitoring system comprising:

an analyte sensor configured for detecting an analyte level of a user;

a processor operably coupled to the analyte sensor; and

a memory operably coupled to the processor, wherein the memory includes instructions stored therein that, when executed by the processor, cause the processor to:

detect the analyte level using the analyte sensor; and

delay an annunciation of an analyte alarm after the analyte level crosses an analyte threshold, wherein an amount of the delay is based on a duration of time in which the analyte level has not exceeded the analyte threshold.

11. The system of claim 10 , wherein the analyte threshold is a low analyte threshold.

12. The system of claim 10 , wherein the analyte level is a glucose level.

13. The system of claim 12 , wherein the analyte level is an interstitial glucose level.

14. The system of claim 10 , further comprising sounding an alarm after the delay.

15. The system of claim 14 , wherein the electronic device comprises a display for user input and output communication.

16. The system of claim 14 , wherein the electronic device is further configured to recommend medication based on the analyte level.

17. The system of claim 14 , wherein the electronic device is further in communication with a medication delivery device.

18. The system of claim 10 , wherein the duration of time corresponds to a duration the analyte level was in a euglycemic range prior to exceeding the analyte threshold.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2019
From: SLOAN, MARK; TAUB, MARC B.; HAYTER, GARY A.; HARPER, WESLEY SCOTT; BUDIMAN, ERWIN S.; WEI, CHARLES
To: ABBOTT DIABETES CARE INC.
Reel/Frame 050266/0954 →
Continuity (5)
Continuation 15282688 · Sep 30, 2016
Division 14076109 · Nov 8, 2013
Continuation 12785144 · May 21, 2010
Provisional Application 61180649 · May 22, 2009
Related Publication 20200016338A1 · Jan 16, 2020
Cited By (3)
US 12,220,558 US 12,315,614 US 12,507,921